TY  - GEN
AU  - Rey, Verónica
AU  - Tornin, Juan
AU  - Alba-Linares, Juan José
AU  - Robledo, Cristina
AU  - Murillo, Dzohara
AU  - Rodríguez, Aida
AU  - Gallego, Borja
AU  - Huergo, Carmen
AU  - Viera, Cristina
AU  - Braña, Alejandro
AU  - Astudillo, Aurora
AU  - Heymann, Dominique
AU  - Szuhai, Karoly
AU  - Bovée, Judith V M G
AU  - Fernandez, Agustín F
AU  - Fraga, Mario F
AU  - Alonso, Javier
AU  - Rodriguez, Rene
PY  - 2024
DO  - 10.1016/j.ebiom.2024.105090
SN  - 2352-3964
UR  - http://hdl.handle.net/20.500.12105/19303
AB  - Background: Sarcomas represent an extensive group of malignant diseases affecting mesodermal tissues. Among sarcomas, the clinical management of chondrosarcomas remains a complex challenge, as high-grade tumours do not respond to current therapies....
LA  - eng
PB  - Elsevier
KW  - Chondrosarcoma
KW  - Enasidenib
KW  - IDH2
KW  - Patient-derived models
KW  - Personalized medicine
KW  - Chondrosarcoma
KW  - Sarcoma
KW  - Bone Neoplasms
KW  - Aminopyridines
KW  - Triazines
KW  - Humans
KW  - Animals
KW  - Mice
KW  - Precision Medicine
KW  - Isocitrate Dehydrogenase
KW  - Mutation
TI  - A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma
TY  - research article
ER  -